Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Racial disparities in analgesic use amongst patients presenting to the emergency department for kidney stones in the United States.

Berger AJ, Wang Y, Rowe C, Chung B, Chang S, Haleblian G.

Am J Emerg Med. 2020 Jan 8. pii: S0735-6757(20)30017-6. doi: 10.1016/j.ajem.2020.01.017. [Epub ahead of print]

PMID:
31987745
2.

Angularly resolved, finely sampled elastic scattering measurements of single cells: requirements for robust organelle size extractions.

Cannaday AE, Sorrells JE, Berger AJ.

J Biomed Opt. 2019 Aug;24(8):1-12. doi: 10.1117/1.JBO.24.8.086502.

3.

Scaffold stiffness influences breast cancer cell invasion via EGFR-linked Mena upregulation and matrix remodeling.

Berger AJ, Renner CM, Hale I, Yang X, Ponik SM, Weisman PS, Masters KS, Kreeger PK.

Matrix Biol. 2019 Jul 16. pii: S0945-053X(19)30104-0. doi: 10.1016/j.matbio.2019.07.006. [Epub ahead of print]

PMID:
31323325
4.

Spatially offset Raman spectroscopy for in vivo bone strength prediction.

Shu C, Chen K, Lynch M, Maher JR, Awad HA, Berger AJ.

Biomed Opt Express. 2018 Sep 12;9(10):4781-4791. doi: 10.1364/BOE.9.004781. eCollection 2018 Oct 1.

5.

Low rates of bone density testing in prostate cancer survivors on androgen-deprivation therapy: where do we go from here?

Harmouch SS, Berger AJ, Cole AP.

BJU Int. 2018 Apr;121(4):492-493. doi: 10.1111/bju.14120. No abstract available.

6.

Decoupling the effects of stiffness and fiber density on cellular behaviors via an interpenetrating network of gelatin-methacrylate and collagen.

Berger AJ, Linsmeier KM, Kreeger PK, Masters KS.

Biomaterials. 2017 Oct;141:125-135. doi: 10.1016/j.biomaterials.2017.06.039. Epub 2017 Jun 29.

7.

Sensitivity of spatially offset Raman spectroscopy (SORS) to subcortical bone tissue.

Feng G, Ochoa M, Maher JR, Awad HA, Berger AJ.

J Biophotonics. 2017 Aug;10(8):990-996. doi: 10.1002/jbio.201600317. Epub 2017 May 2.

8.

Methodology for high-yield acquisition of functional near-infrared spectroscopy data from alert, upright infants.

Goodwin JR, Cannaday AE, Palmeri HG, Di Costanzo A, Emberson LL, Aslin RN, Berger AJ.

Neurophotonics. 2016 Jul;3(3):031415. doi: 10.1117/1.NPh.3.3.031415. Epub 2016 Jul 28.

9.

Sequential Right and Left Ventricular Assessment in Posttetralogy of Fallot Patients with Significant Pulmonary Regurgitation.

Wijesekera VA, Raju R, Precious B, Berger AJ, Kiess MC, Leipsic JA, Grewal J.

Congenit Heart Dis. 2016 Dec;11(6):606-614. doi: 10.1111/chd.12354. Epub 2016 May 26.

PMID:
27225732
10.

Isolating the effects of surface vasculature in infant neuroimaging using short-distance optical channels: a combination of local and global effects.

Emberson LL, Crosswhite SL, Goodwin JR, Berger AJ, Aslin RN.

Neurophotonics. 2016 Jul;3(3):031406. doi: 10.1117/1.NPh.3.3.031406. Epub 2016 Apr 19.

11.

Engineering approaches to study fibrosis in 3-D in vitro systems.

Porras AM, Hutson HN, Berger AJ, Masters KS.

Curr Opin Biotechnol. 2016 Aug;40:24-30. doi: 10.1016/j.copbio.2016.02.006. Epub 2016 Feb 27. Review.

12.

In Reply.

Berger AJ, Meals R.

J Hand Surg Am. 2016 Mar;41(3):488-9. doi: 10.1016/j.jhsa.2015.12.018. No abstract available.

PMID:
26920117
13.

The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR.

Zhou L, Chen S, Zhang Y, Kmieciak M, Leng Y, Li L, Lin H, Rizzo KA, Dumur CI, Ferreira-Gonzalez A, Rahmani M, Povirk L, Chalasani S, Berger AJ, Dai Y, Grant S.

Blood. 2016 May 5;127(18):2219-30. doi: 10.1182/blood-2015-06-653717. Epub 2016 Feb 5.

14.

KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.

Chattopadhyay N, Berger AJ, Koenig E, Bannerman B, Garnsey J, Bernard H, Hales P, Maldonado Lopez A, Yang Y, Donelan J, Jordan K, Tirrell S, Stringer B, Xia C, Hather G, Galvin K, Manfredi M, Rhodes N, Amidon B.

PLoS One. 2015 Dec 28;10(12):e0144825. doi: 10.1371/journal.pone.0144825. eCollection 2015.

15.

Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma.

Shah JJ, Jakubowiak AJ, O'Connor OA, Orlowski RZ, Harvey RD, Smith MR, Lebovic D, Diefenbach C, Kelly K, Hua Z, Berger AJ, Mulligan G, Faessel HM, Tirrell S, Dezube BJ, Lonial S.

Clin Cancer Res. 2016 Jan 1;22(1):34-43. doi: 10.1158/1078-0432.CCR-15-1237. Epub 2015 Nov 11.

16.

Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid Tumors.

Sarantopoulos J, Shapiro GI, Cohen RB, Clark JW, Kauh JS, Weiss GJ, Cleary JM, Mahalingam D, Pickard MD, Faessel HM, Berger AJ, Burke K, Mulligan G, Dezube BJ, Harvey RD.

Clin Cancer Res. 2016 Feb 15;22(4):847-57. doi: 10.1158/1078-0432.CCR-15-1338. Epub 2015 Sep 30.

17.

Short-channel functional near-infrared spectroscopy regressions improve when source-detector separation is reduced.

Goodwin JR, Gaudet CR, Berger AJ.

Neurophotonics. 2014 Jul;1(1):015002. doi: 10.1117/1.NPh.1.1.015002. Epub 2014 Jul 15.

18.

In Reply.

Berger AJ, Meals RA.

J Hand Surg Am. 2015 Jul;40(7):1506. doi: 10.1016/j.jhsa.2015.04.042. No abstract available.

PMID:
26095061
19.

Aberrant lymphatic drainage and risk for melanoma recurrence after negative sentinel node biopsy in middle-aged and older men.

Kaveh AH, Seminara NM, Barnes MA, Berger AJ, Chen FW, Yao M, Johnson D, Parsa S, Quon A, Swetter SM, Sunwoo JB.

Head Neck. 2016 Apr;38 Suppl 1:E754-60. doi: 10.1002/hed.24094. Epub 2015 Jul 14.

PMID:
25914266
20.

Phase 1 study of ixazomib, an investigational proteasome inhibitor, in advanced non-hematologic malignancies.

Smith DC, Kalebic T, Infante JR, Siu LL, Sullivan D, Vlahovic G, Kauh JS, Gao F, Berger AJ, Tirrell S, Gupta N, Di Bacco A, Berg D, Liu G, Lin J, Hui AM, Thompson JA.

Invest New Drugs. 2015 Jun;33(3):652-63. doi: 10.1007/s10637-015-0230-x. Epub 2015 Mar 18.

21.

Management of osteoarthrosis of the thumb joints.

Berger AJ, Meals RA.

J Hand Surg Am. 2015 Apr;40(4):843-50. doi: 10.1016/j.jhsa.2014.11.026. Epub 2015 Mar 6. Review.

PMID:
25754790
22.

Regulation of T cell receptor complex-mediated signaling by ubiquitin and ubiquitin-like modifications.

Friend SF, Deason-Towne F, Peterson LK, Berger AJ, Dragone LL.

Am J Clin Exp Immunol. 2014 Dec 5;3(3):107-23. eCollection 2014. Review.

23.

Correlation of clinical disease severity to radiographic thumb osteoarthritis index.

Ladd AL, Messana JM, Berger AJ, Weiss AP.

J Hand Surg Am. 2015 Mar;40(3):474-82. doi: 10.1016/j.jhsa.2014.11.021. Epub 2015 Jan 21.

24.

A versatile LabVIEW and field-programmable gate array-based scanning probe microscope for in operando electronic device characterization.

Berger AJ, Page MR, Jacob J, Young JR, Lewis J, Wenzel L, Bhallamudi VP, Johnston-Halperin E, Pelekhov DV, Hammel PC.

Rev Sci Instrum. 2014 Dec;85(12):123702. doi: 10.1063/1.4902934.

PMID:
25554296
25.

Chronic cutaneous chest wall fistula and gallstone empyema due to retained gallstones.

Gaster RS, Berger AJ, Ahmadi-Kashani M, Shrager JB, Lee GK.

BMJ Case Rep. 2014 Aug 14;2014. pii: bcr2013010159. doi: 10.1136/bcr-2013-010159.

26.

The effect of spin transport on spin lifetime in nanoscale systems.

Cardellino J, Scozzaro N, Herman M, Berger AJ, Zhang C, Fong KC, Jayaprakash C, Pelekhov DV, Hammel PC.

Nat Nanotechnol. 2014 May;9(5):343-7. doi: 10.1038/nnano.2014.39. Epub 2014 Mar 23.

PMID:
24658171
27.

Preclinical activity of the oral proteasome inhibitor MLN9708 in Myeloma bone disease.

Garcia-Gomez A, Quwaider D, Canavese M, Ocio EM, Tian Z, Blanco JF, Berger AJ, Ortiz-de-Solorzano C, Hernández-Iglesias T, Martens AC, Groen RW, Mateo-Urdiales J, Fraile S, Galarraga M, Chauhan D, San Miguel JF, Raje N, Garayoa M.

Clin Cancer Res. 2014 Mar 15;20(6):1542-54. doi: 10.1158/1078-0432.CCR-13-1657. Epub 2014 Jan 31.

28.

Angular-domain scattering interferometry.

Shipp DW, Qian R, Berger AJ.

Opt Lett. 2013 Nov 15;38(22):4750-3. doi: 10.1364/OL.38.004750.

PMID:
24322123
29.

(18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib.

Duncan K, Rosean TR, Tompkins VS, Olivier A, Sompallae R, Zhan F, Tricot G, Acevedo MR, Ponto LL, Walsh SA, Tygrett LT, Berger AJ, Waldschmidt T, Morse HC 3rd, Sunderland JJ, Janz S.

Blood Cancer J. 2013 Nov 29;3:e165. doi: 10.1038/bcj.2013.61.

30.

Cutting too deep? Assessing the impact of a shorter surgery clerkship on students' clinical skills and knowledge.

Bhatia ND, Gillespie CC, Berger AJ, Hochberg MS, Ogilvie JB.

Am J Surg. 2014 Feb;207(2):209-12. doi: 10.1016/j.amjsurg.2013.07.035. Epub 2013 Oct 23.

PMID:
24238603
31.

The discovery of a reciprocal relationship between tyrosine-kinase signaling and cullin neddylation.

Friend SF, Peterson LK, Treacy E, Stefanski AL, Sosinowski T, Pennock ND, Berger AJ, Winn VD, Dragone LL.

PLoS One. 2013 Oct 4;8(10):e75200. doi: 10.1371/journal.pone.0075200. eCollection 2013.

32.

Experimental demonstration of scanned spin-precession microscopy.

Bhallamudi VP, Wolfe CS, Amin VP, Labanowski DE, Berger AJ, Stroud D, Sinova J, Hammel PC.

Phys Rev Lett. 2013 Sep 13;111(11):117201. Epub 2013 Sep 10.

PMID:
24074116
33.

Conformational analysis of NMDA receptor GluN1, GluN2, and GluN3 ligand-binding domains reveals subtype-specific characteristics.

Yao Y, Belcher J, Berger AJ, Mayer ML, Lau AY.

Structure. 2013 Oct 8;21(10):1788-99. doi: 10.1016/j.str.2013.07.011. Epub 2013 Aug 22.

34.

Overcoming platinum resistance in preclinical models of ovarian cancer using the neddylation inhibitor MLN4924.

Jazaeri AA, Shibata E, Park J, Bryant JL, Conaway MR, Modesitt SC, Smith PG, Milhollen MA, Berger AJ, Dutta A.

Mol Cancer Ther. 2013 Oct;12(10):1958-67. doi: 10.1158/1535-7163.MCT-12-1028. Epub 2013 Aug 12.

35.

Intra- and interobserver reliability of the Eaton classification for trapeziometacarpal arthritis: a systematic review.

Berger AJ, Momeni A, Ladd AL.

Clin Orthop Relat Res. 2014 Apr;472(4):1155-9. doi: 10.1007/s11999-013-3208-z. Review.

36.

Analysis of high-affinity assembly for AMPA receptor amino-terminal domains.

Zhao H, Berger AJ, Brown PH, Kumar J, Balbo A, May CA, Casillas E Jr, Laue TM, Patterson GH, Mayer ML, Schuck P.

J Gen Physiol. 2013 Jun;141(6):747-9. No abstract available.

37.

Overconstrained library-based fitting method reveals age- and disease-related differences in transcutaneous Raman spectra of murine bones.

Maher JR, Inzana JA, Awad HA, Berger AJ.

J Biomed Opt. 2013 Jul;18(7):077001. doi: 10.1117/1.JBO.18.7.077001.

38.

Histologic analysis of fetal bovine derived acellular dermal matrix in tissue expander breast reconstruction.

Gaster RS, Berger AJ, Monica SD, Sweeney RT, Endress R, Lee GK.

Ann Plast Surg. 2013 Apr;70(4):447-53. doi: 10.1097/SAP.0b013e31827e55af.

PMID:
23486129
39.

Development of an affordable system for personalized video-documented surgical skill analysis for surgical residency training.

Berger AJ, Gaster RS, Lee GK.

Ann Plast Surg. 2013 Apr;70(4):442-6. doi: 10.1097/SAP.0b013e31827e513c.

PMID:
23486125
40.

Bone fragility beyond strength and mineral density: Raman spectroscopy predicts femoral fracture toughness in a murine model of rheumatoid arthritis.

Inzana JA, Maher JR, Takahata M, Schwarz EM, Berger AJ, Awad HA.

J Biomech. 2013 Feb 22;46(4):723-30. doi: 10.1016/j.jbiomech.2012.11.039. Epub 2012 Dec 20.

41.

Growth and development of the orbit.

Berger AJ, Kahn D.

Oral Maxillofac Surg Clin North Am. 2012 Nov;24(4):545-55. doi: 10.1016/j.coms.2012.08.001. Review.

PMID:
23107427
42.

Heavy metal lead exposure, osteoporotic-like phenotype in an animal model, and depression of Wnt signaling.

Beier EE, Maher JR, Sheu TJ, Cory-Slechta DA, Berger AJ, Zuscik MJ, Puzas JE.

Environ Health Perspect. 2013 Jan;121(1):97-104. doi: 10.1289/ehp.1205374. Epub 2012 Oct 19. Erratum in: Environ Health Perspect. 2013 Feb;121(2):a43.

43.

Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells.

Tian Z, Zhao JJ, Tai YT, Amin SB, Hu Y, Berger AJ, Richardson P, Chauhan D, Anderson KC.

Blood. 2012 Nov 8;120(19):3958-67. doi: 10.1182/blood-2012-01-401794. Epub 2012 Sep 14.

44.

Mechanisms of bone fragility in a mouse model of glucocorticoid-treated rheumatoid arthritis: implications for insufficiency fracture risk.

Takahata M, Maher JR, Juneja SC, Inzana J, Xing L, Schwarz EM, Berger AJ, Awad HA.

Arthritis Rheum. 2012 Nov;64(11):3649-59. doi: 10.1002/art.34639.

45.

Raman microspectroscopy for species identification and mapping within bacterial biofilms.

Beier BD, Quivey RG, Berger AJ.

AMB Express. 2012 Jul 13;2(1):35. doi: 10.1186/2191-0855-2-35.

46.

Analysis of high-affinity assembly for AMPA receptor amino-terminal domains.

Zhao H, Berger AJ, Brown PH, Kumar J, Balbo A, May CA, Casillas E Jr, Laue TM, Patterson GH, Mayer ML, Schuck P.

J Gen Physiol. 2012 May;139(5):371-88. doi: 10.1085/jgp.201210770. Epub 2012 Apr 16. Erratum in: J Gen Physiol. 2013 Jun;141(6):747-9.

47.

Lack of an endogenous GABAA receptor-mediated tonic current in hypoglossal motoneurons.

Numata JM, van Brederode JF, Berger AJ.

J Physiol. 2012 Jul 1;590(13):2965-76. doi: 10.1113/jphysiol.2012.231944. Epub 2012 Apr 10.

48.

Malignant ameloblastoma: concurrent presentation of primary and distant disease and review of the literature.

Berger AJ, Son J, Desai NK.

J Oral Maxillofac Surg. 2012 Oct;70(10):2316-26. doi: 10.1016/j.joms.2011.11.004. Epub 2012 Jan 24. Review.

PMID:
22281130
49.

Assessment of medical student clinical reasoning by "lay" vs physician raters: inter-rater reliability using a scoring guide in a multidisciplinary objective structured clinical examination.

Berger AJ, Gillespie CC, Tewksbury LR, Overstreet IM, Tsai MC, Kalet AL, Ogilvie JB.

Am J Surg. 2012 Jan;203(1):81-6. doi: 10.1016/j.amjsurg.2011.08.003.

PMID:
22172486
50.

Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies.

Lee EC, Fitzgerald M, Bannerman B, Donelan J, Bano K, Terkelsen J, Bradley DP, Subakan O, Silva MD, Liu R, Pickard M, Li Z, Tayber O, Li P, Hales P, Carsillo M, Neppalli VT, Berger AJ, Kupperman E, Manfredi M, Bolen JB, Van Ness B, Janz S.

Clin Cancer Res. 2011 Dec 1;17(23):7313-23. doi: 10.1158/1078-0432.CCR-11-0636. Epub 2011 Sep 8.

Supplemental Content

Loading ...
Support Center